Clik here to view.
ARIAD Announces Regulatory Approval for Iclusig® (ponatinib) in Japan
CAMBRIDGE, Mass. ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that its partner Otsuka Pharmaceutical Co., Ltd. (Otsuka) has received approval from the Japanese Pharmaceuticals and...
View ArticleClik here to view.
Zymeworks and Daiichi Sankyo Announce Immuno-Oncology Cross-Licensing...
VANCOUVER, British Columbia & TOKYO & PARSIPPANY, N.J. Zymeworks Inc., a clinical-stage biopharmaceutical company discovering and developing innovative multi-functional protein-based...
View ArticleClik here to view.
Agilent Technologies and Burning Rock Sign Agreement on Molecular Diagnostics
SANTA CLARA, Calif. & GUANGZHOU, China Agilent Technologies Inc. (NYSE:A) and Burning Rock today announced they have signed an agreement under which Burning Rock will develop cancer diagnostics...
View ArticleClik here to view.
22ndセンチュリーの超低ニコチン禁煙製品「X-22」が圧倒的多数の医師と消費者から支持されたことが報告
米ニューヨーク州クラレンス （ビジネスワイヤ） — タバコの有害性低減でリードする植物バイオテクノロジー企業の22ndセンチュリー・グループ（NYSE MKT:XXII）は、2件の独立調査から得られた結果を発表しました。これらの結果は、消費者からの強い需要が、当社において開発中の禁煙補助製品X-22を処方したいという医師の意思に反映されていることを示しています。...
View ArticleClik here to view.
Thermo Fisher Scientific Expands Global Footprint to Support Cell and Gene...
TOKYO To help meet increasing demand for cell and gene therapy clinical trial support around the globe, Thermo Fisher Scientific, the world leader in serving science, today announced the expansion...
View ArticleClik here to view.
Samsung Bioepis’ Marketing Authorization Application for SB3 Trastuzumab...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency (EMA) has accepted for review the company’s Marketing Authorization Application (MAA) for SB3, a...
View ArticleClik here to view.
MabPlex Announces Expansion of cGMP Manufacturing Facilities
FREMONT, Calif. & YANTAI, China MabPlex International Ltd. (MabPlex), a global CRO/CMO service provider specializing in the development and manufacturing of antibody therapeutics and...
View ArticleClik here to view.
Xcell Biosciences Announces Two New International Distributors and Multiple...
SAN FRANCISCO Xcell Biosciences, Inc., today announced it has signed agreements with two international distributors and made a number of international sales for its Avatar™ system. Cambridge...
View ArticleClik here to view.
Alzheon to Present at Upcoming Asian Healthcare and Scientific Conferences
FRAMINGHAM, Mass. Alzheon Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease and other neurological and psychiatric...
View ArticleClik here to view.
Acelity Announces Expiration of and Final Results for the Exchange Offer with...
SAN ANTONIO Acelity L.P. Inc. (“Acelity”), a global advanced wound care and regenerative medicine company, today announced the final results of the private offer to Eligible Holders (as defined...
View ArticleClik here to view.
ReplicorがAASLD 2016の最新演題セッションでHBV臨床データを公表へ
ニューヨーク （ビジネスワイヤ） — 慢性B型肝炎／D型肝炎の患者向け治療薬に的を絞った非公開バイオ製薬企業のReplicor Inc.は本日、直近のREP 401臨床試験から得た中間解析の結果が、米ボストンで2016年11月11～15日に開催される米国肝臓学会（AASLD）年次総会で、最新演題の口頭アブストラクトセッションとして発表するために選定されたと発表しました。 REP...
View ArticleClik here to view.
10x Genomics’ GemCode™ Technology Utilized for de novo Assembly and Phasing...
PLEASANTON, Calif. 10x Genomics, a company focused on improving and broadening the application of genomic information, today announced the use of the GemCodeTM Technology in a new publication in the...
View ArticleClik here to view.
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership
JERUSALEM and INCHEON, South Korea Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA), Celltrion, Inc. and Celltrion Healthcare today announce that the companies have entered into an exclusive...
View ArticleClik here to view.
IncellDxの腫瘍免疫療法向け定量的アッセイOncoTect iOに関する新研究が論文に掲載
米カリフォルニア州メンロパーク （ビジネスワイヤ） — 単一細胞を使用した精密医療技術の企業IncellDx, Inc.は本日、国際的な査読医学誌Cancer Immunology, Immunotherapyが、「非酵素的組織分散とフローサイトメトリーを使用した非小細胞肺がん（NSCLC）での腫瘍細胞および免疫細胞におけるPD-L1/PD-1発現の定量」（Quantification of...
View ArticleClik here to view.
Agilent Technologies Showcases Innovative Laboratory Solutions at analytica...
SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE:A) will showcase its latest innovations at analytica China 2016, the leading Chinese exhibition for laboratory technology, analysis, biotechnology...
View ArticleClik here to view.
珀金埃尔默新型QSight™ 三重四极杆液质联用仪帮助分析实验室实现高灵敏度、高通量和高效率的样品分析进程
中国上海 (美国商业资讯)– 今日，全球领先的致力于改善健康领域的创新型企业珀金埃尔默企业管理（上海）有限公司（以下简称：珀金埃尔默）在上海新国际博览中心举行的慕尼黑上海分析生化展发布会上隆重推出QSight™三重四极杆液质联用仪。慕尼黑上海分析生化展是实验室技术、分析、生物技术及诊断领域的国际性博览会。珀金埃尔默展位：N2馆2100号。...
View ArticleClik here to view.
PerkinElmer’s New QSight™ Triple Quadrupole LC/MS/MS System Delivers High...
WALTHAM, Mass. & SHANGHAI (analytica Booth #N2, 2100) PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its new QSight™ Triple...
View ArticleClik here to view.
IncellDx发表定量免疫肿瘤学检测OncoTect iO的新研究
加州门罗帕克 (美国商业资讯) — 单细胞精准医学公司IncellDx, Inc.今天宣布，国际性同行评议医学杂志《癌症免疫学与免疫治疗》(Cancer Immunology, Immunotherapy)已发表了一篇题为“采用非酶解组织解离和流式细胞计量术对非小细胞肺癌(NSCLC)肿瘤和免疫细胞上PD-L1 和PD-1表达进行定量”的稿件。公司创始人、首席执行官Bruce...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Lamotrigine Orally...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Lamotrigine Orally Disintegrating Tablets in 25 mg,...
View ArticleClik here to view.
クインタイルズIMS：合併により世界一流の総合情報／技術駆使型ヘルスケアサービスプロバイダーが誕生
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 米コネティカット州ダンバリー & 米ノースカロライナ州リサーチ・トライアングル・パーク （ビジネスワイヤ） —...
View Article